Clinical Trials in Austin

Showing 12561-12580 of 13,060 trials

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

NCT00143247

This is a long-term safety study for Phase 2 subjects who choose to remain on Exubera® (inhaled insulin).

Pfizer173 participantsStarted Mar 2003

San Diego, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +9 more locations

COMPLETEDPhase 1< 1 mile

Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil

NCT00963027

The purpose of this study is to evaluate the effect of esomeprazole, a proton pump inhibitor, on treprostinil pharmacokinetics.

Hypertension, PulmonaryPulmonary Arterial Hypertension

United Therapeutics30 participantsStarted Sep 2009

Austin, Texas, United States

COMPLETEDPhase 362 miles

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

NCT00259012

The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months.

Gastroesophageal Reflux

Wyeth is now a wholly owned subsidiary of Pfizer67 participantsStarted Nov 2005

Little Rock, Arkansas, United States • Loma Linda, California, United States • San Diego, California, United States +28 more locations

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil

Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD

Find Trials by Condition in Austin

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

Novel Rinse to Treat in Oral Candidiasis in Cancer Patients

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Herpetic Eye Disease Study (HEDS) II

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Diabetes Control and Complications Trial (DCCT)

A Trial of Skin Care Protocols for Facial Resurfacing

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.